D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBIO
3651
DELISTED
Generation Bio
GBIO
| $366K | ﹤0.01% |
34,492
-14,323
| -29% | -$255K |
|
3652
Eagle Materials
EXP
$6.69B
| $365K | ﹤0.01% |
1,479
-285
| -16% | -$82.2K |
|
3653
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
| $363K | ﹤0.01% |
8,437
+1,899
| +29% | +$86.3K |
|
3654
SLR Investment Corp
SLRC
$705M
| $363K | ﹤0.01% |
22,434
+3,354
| +18% | +$53.3K |
|
3655
CALL
Chord Energy
CHRD
$7.42B
| $362K | ﹤0.01% |
+3,100
| New | +$390K |
|
3656
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $362K | ﹤0.01% |
+7,326
| New | +$371K |
|
3657
Hingham Institution for Saving
HIFS
$613M
| $362K | ﹤0.01% |
1,424
+100
| +8% | +$26.5K |
|
3658
First Advantage
FA
$3.43B
| $362K | ﹤0.01% |
19,315
-38,419
| -67% | -$729K |
|
3659
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
| $361K | ﹤0.01% |
1,424
-599
| -30% | -$154K |
|
3660
State Street SPDR S&P Global Infrastructure ETF
GII
$929M
| $360K | ﹤0.01% |
+6,076
| New | +$373K |
|
3661
Teekay Tankers
TNK
$2.63B
| $359K | ﹤0.01% |
9,023
+3,168
| +54% | +$147K |
|
3662
CALL
M/I Homes
MHO
$3.81B
| $359K | ﹤0.01% |
2,700
-18,100
| -87% | -$2.85M |
|
3663
Synopsys
SNPS
$74.5B
| $358K | ﹤0.01% |
737
-12,907
| -95% | -$6.75M |
|
3664
Polestar Automotive Holding UK
PSNY
$2.04B
| $357K | ﹤0.01% |
11,327
+4,653
| +70% | +$169K |
|
3665
PUT
Curtiss-Wright
CW
$27.5B
| $355K | ﹤0.01% |
+1,000
| New | +$360K |
|
3666
Tango Therapeutics
TNGX
$4.35B
| $355K | ﹤0.01% |
+114,827
| New | +$533K |
|
3667
iShares US Regional Banks ETF
IAT
$673M
| $353K | ﹤0.01% |
7,001
-11,695
| -63% | -$604K |
|
3668
Werner Enterprises
WERN
$2.42B
| $352K | ﹤0.01% |
9,802
-56,494
| -85% | -$2.16M |
|
3669
Boston Omaha
BOC
$434M
| $352K | ﹤0.01% |
24,817
-7,885
| -24% | -$117K |
|
3670
Limbach Holdings
LMB
$886M
| $351K | ﹤0.01% |
4,100
-1,865
| -31% | -$164K |
|
3671
South Plains Financial
SPFI
$838M
| $350K | ﹤0.01% |
10,068
-3,313
| -25% | -$120K |
|
|
CSW
3672
CSW Industrials
CSW
$4.78B
| $350K | ﹤0.01% |
991
| – | – |
|
3673
CALL
Ovintiv
OVV
$16.6B
| $348K | ﹤0.01% |
8,600
-10,600
| -55% | -$441K |
|
3674
loanDepot
LDI
$541M
| $348K | ﹤0.01% |
170,441
+110,448
| +184% | +$246K |
|
|
DHIL
3675
DELISTED
Diamond Hill
DHIL
| $347K | ﹤0.01% |
2,235
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.